Status:
COMPLETED
Efficacy and Safety of Pitavastatin in a Real-world Setting
Lead Sponsor:
JW Pharmaceutical
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
Brief Summary
The prospective, observational, non-comparative trial in South Korea was designed to evaluate the efficacy and safety of pitavastatin (Livalo) in clinical practice in 28,343 patients.
Detailed Description
This study was conducted in 893 facilities in Korea from 2 Apr 2012 to 1 Apr 2017. This study was designed to administer 1mg, 2mg, or 4mg pitavastatin to patients with hyperlipidemia at the age of 20 ...
Eligibility Criteria
Inclusion
- Patients in need of statin treatment who are taking or are planning to take Livalo tablets, or who are taking other statins or are planning to change to Livalo tablets.
Exclusion
- Patients with hypersensitivity to pitavastatin
- Patients with active liver disease or untranslated transaminase levels Patients with a constant rise in
- Patients with severe liver failure or biliary obstruction and patients with cholestasis
- Patients who are receiving cyclosporine
- Myopathy patients
- Pregnant women or women of childbearing age and lactating women
- Children
- Patients with genetic problems, such as galactose intolerance, Lapp lactose deficiency or glucose-galactose
- Patients deemed inappropriate by the investigator
Key Trial Info
Start Date :
April 2 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2017
Estimated Enrollment :
28343 Patients enrolled
Trial Details
Trial ID
NCT04402112
Start Date
April 2 2012
End Date
August 1 2017
Last Update
April 19 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.